|
KDM5C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.261200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.638400E-01 |
| Normal-vs-Stage2 |
9.787800E-01 |
| Normal-vs-Stage3 |
7.894500E-02 |
| Normal-vs-Stage4 |
2.122400E-02 |
| Stage1-vs-Stage2 |
6.573600E-01 |
| Stage1-vs-Stage3 |
5.576000E-02 |
| Stage1-vs-Stage4 |
1.246370E-02 |
| Stage2-vs-Stage3 |
8.930300E-02 |
| Stage2-vs-Stage4 |
2.593500E-02 |
| Stage3-vs-Stage4 |
5.253600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.903600E-01 |
| Normal-vs-AfricanAmerican |
4.667400E-01 |
| Normal-vs-Asian |
7.890200E-01 |
| Caucasian-vs-AfricanAmerican |
1.563350E-01 |
| Caucasian-vs-Asian |
6.285800E-01 |
| AfricanAmerican-vs-Asian |
3.700400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22480026121252E-10 |
| Normal-vs-Female |
2.126600E-01 |
| Male-vs-Female |
1.62447832963153E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.671400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.287400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.184200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.102400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.577400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.680300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.592200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.582300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.812200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.888580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.649600E-02 |
| Classical-VS-Follicular |
1.307570E-01 |
| Classical-VS-Other |
7.219700E-02 |
| Classical-VS-Normal |
8.149200E-01 |
| Tall-VS-Follicular |
2.713000E-01 |
| Tall-VS-Other |
4.528800E-01 |
| Tall-VS-Normal |
3.005600E-02 |
| Follicular-VS-Other |
2.244400E-01 |
| Follicular-VS-Normal |
2.165800E-01 |
| Other-VS-Normal |
5.349500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.570200E-01 |
| Normal-vs-N1 |
3.680800E-01 |
| N0-vs-N1 |
8.500800E-01 |
|
|
